Hirschsprung's disease: a review

Authors

  • Alicia Del Carmen Rodríguez Martínez Department of Pediatrics, General Hospital of Mexico “Dr. Eduardo Liceaga”, CDMX, Mexico
  • Sofia Barrientos-Villegas Department of SCIRCES, UCES, Medellín, Colombia
  • Patricia M. Palacios-Rodríguez Department of Pediatric Surgery, National Institute of Pediatrics, CDMX, Mexico
  • Erick Fernando Hernández Department of General Surgery, General Hospital of Mexico “Dr. Eduardo Liceaga”, CDMX, Mexico
  • Isaim Paris Martínez-Sosa Department of Angiology, Vascular and Endovascular Surgery, Hospital Regional Lic, Adolfo López Mateos, Mexico
  • Nalleli Durán-López Department of Pathological Anatomy, Hospital Médica Sur, Mexico City, Mexico
  • Alan I. Valderrama-Treviño Department of Angiology, Vascular and Endovascular Surgery, General Hospital of Mexico “Dr. Eduardo Liceaga”, CDMX, Mexico

DOI:

https://doi.org/10.18203/2349-2902.isj20242147

Keywords:

HD, Treatment, Management, Ethiopathogenesis, Neural crest cells, Intestinal function

Abstract

Hirschsprung disease (HD) is a congenital condition that affects intestinal function due to the absence of ganglion cells in the myenteric and submucosal plexus of the colon. This absence causes difficulty in intestinal relaxation and, consequently, normal intestinal evacuation, resulting in severe constipation from birth or early childhood. At the genetic level, mutations have been identified in genes such as RET, involved in the migration and differentiation of neural crest cells. The diagnosis is based on rectal biopsies that show the absence of ganglion cells. The main treatment is surgical, with techniques such as rectosigmoidectomy or pull-through to restore intestinal function. Despite advances, patients can experience complications such as fecal incontinence. Multidisciplinary management is crucial to improve the patient's quality of life.

Metrics

Metrics Loading ...

References

Amiel J, Lyonnet S. Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet. 2001;38(11):729-39.

Rojas-Gutiérrez CD, Haro-Cruz JS, Cabrera-Eraso DF, Torres-García VM, Salas-Álvarez JC, Valencia-Jiménez JO, et al. Reporte de caso: vólvulo de sigmoides en un adulto joven, una manifestación de enfermedad de Hirschsprung. Cir Cir. 2022;90(6):842-7.

Weber Estrada N. Enfermedad de Hirschsprung. Rev Med Costa Rica Centroamerica LXI. 2012;(602):251-6.

Rocca AM, Nastri M, Takeda S, Neder D, Mortarini A, Paz E, Lavorgna S, Bazo M, Dibenedetto V. Recommendations for the diagnosis and treatment of persistent postsurgical symptoms in Hirschsprung disease. Arch Argent Pediatr. 2020;118(5):350-7.

KA Santos-Jasso. Enfermedad de Hirschsprung. Acta Pediatr México. 2017;38(1):72-8.

Guevara MJ, López-Cortés A, Jaramillo-Koupermann G, Cabrera A, Rodríguez R, Franco D, et al. Polimorfismos genéticos del proto-oncogén RET asociados con la enfermedad de Hirschsprung en niños de la población ecuatoriana. Rev Med Vozandes. 2012;23:97-104.

Mabula JB, Kayange NM, Manyama M, Chandika AB, Rambau PF, Chalya PL. Hirschsprung 's disease in children: a five year experience at a university teaching hospital in Northwestern Tanzania. BMC Res Notes. 2014;7:410.

Nasr A, Sullivan KJ, Chan EW, Wong CA, Benchimol EI. Validation of algorithms to determine incidence of Hirschsprung disease in Ontario, Canada: a population-based study using health administrative data. Clin Epidemiol. 2017;9:579-90.

Lorente-Ros M, Andrés AM, Sánchez-Galán A, Amiñoso C, García S, Lapunzina P, et al. New mutations associated with Hirschsprung disease. An Pediatr (Engl Ed). 2020;93(4):222-7.

Emison ES, Garcia-Barcelo M, Grice EA, Lantieri F, Amiel J, Burzynski G, et al. Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. Am J Hum Genet. 2010;87(1):60-74.

Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, et al. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994;367(6461):378-80.

Ali A, Haider F, Alhindi S. The Prevalence and Clinical Profile of Hirschsprung’s Disease at a Tertiary Hospital in Bahrain. Cureus. 2021;13(1):e12480

Uylas U, Gunes O, Kayaalp C. Hirschsprung's Disease Complicated by Sigmoid Volvulus: A Systematic Review. Balkan Med J. 2021;38(1):1-6.

Neuvonen MI, Kyrklund K, Rintala RJ, Pakarinen MP. Bowel function and quality of life after transanal endorectal pull-through for Hirschsprung disease: controlled outcomes up to adulthood. Ann Surg. 2017;265(3):622-9.

Montalva L, Cheng LS, Kapur R, Langer JC, Berrebi D, Kyrklund K, et al. Hirschsprung disease. Nat Rev Dis Primers. 2023;9(1):54.

Crehuet Gramatyka C, Gutiérrez San Román R, Fonseca Martín J, Barrios Fontoba A, Mínguez Gómez P, Ortolá Fortes I, et al. Evaluación a largo plazo de la cirugía transanal con sutura automática en la enfermedad de Hirschsprung. Cir Pediatr. 2019;32:195-200.

Oyania F, Kotagal M, Wesonga AS, Nimanya SA, Situma M. Pull-Through for Hirschsprung 's Disease: Insights for Limited-Resource Settings from Mbarara. J Surg Res. 2024;293:217-22.

Defilippi GC, Salvador UV, Larach KA. Diagnóstico y tratamiento de la constipación crónica. Rev Méd Clíni Las Condes. 2013;24(2):277-86.

Levitt MA, Dickie B, Peña A. Evaluation and treatment of the patient with Hirschsprung disease who is not doing well after a pull-through procedure. Seminars Pediatr Surg. 2010;19(2):146-53.

Downloads

Published

2024-07-29

How to Cite

Martínez, A. D. C. R., Barrientos-Villegas, S., Palacios-Rodríguez P. M., Hernández, E. F., Martínez-Sosa, I. P., Durán-López, N., & Valderrama-Treviño, A. I. (2024). Hirschsprung’s disease: a review. International Surgery Journal, 11(8), 1428–1432. https://doi.org/10.18203/2349-2902.isj20242147

Issue

Section

Review Articles